User profiles for G. Tajti
 | Gábor TajtiMedical University of Vienna Verified email at meduniwien.ac.at Cited by 380 |
The voltage-gated potassium channel KV1. 3 as a therapeutic target for venom-derived peptides
The voltage-gated potassium channel K V 1.3 is a well-established therapeutic target for a
range of autoimmune diseases, in addition to being the site of action of many venom-derived …
range of autoimmune diseases, in addition to being the site of action of many venom-derived …
[HTML][HTML] Time to kill and time to heal: the multifaceted role of lactoferrin and lactoferricin in host defense
…, T Moskalets, R Skrabana, O Cehlar, G Tajti… - Pharmaceutics, 2023 - mdpi.com
… a digestion of 5 g of recombinant hLF in the stomach and the small intestine of ileostomy
patients over 24 h, while the second assessed the digestion of 4.5 g of bLF in stomachs of …
patients over 24 h, while the second assessed the digestion of 4.5 g of bLF in stomachs of …
[HTML][HTML] SARS-CoV-2-mRNA booster vaccination reverses non-responsiveness and early antibody waning in immunocompromised patients–a phase four study …
…, L Weseslindtner, G Tajti… - Frontiers in …, 2022 - frontiersin.org
Background Individuals with secondary immunodeficiencies belong to the most vulnerable
groups to succumb to COVID-19 and thus are prioritized for SARS-CoV-2 vaccination. …
groups to succumb to COVID-19 and thus are prioritized for SARS-CoV-2 vaccination. …
[HTML][HTML] The Kv1.3 K+ channel in the immune system and its “precision pharmacology” using peptide toxins
Since the discovery of the Kv1.3 voltage-gated K + channel in human T cells in 1984, ion
channels are considered crucial elements of the signal transduction machinery in the immune …
channels are considered crucial elements of the signal transduction machinery in the immune …
[HTML][HTML] Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis
… The short-term in vivo precision error for L2–L4 lumbar spine is 0.012 g/cm 2 (LSC = 0.034
g/cm 2 at 95% confidence level) and femur neck is 0.013 g/cm 2 (LSC = 0.035 g/cm 2 at 95% …
g/cm 2 at 95% confidence level) and femur neck is 0.013 g/cm 2 (LSC = 0.035 g/cm 2 at 95% …
FNDC5/irisin, a molecular target for boosting reward-related learning and motivation
Interventions focusing on the prevention and treatment of chronic non-communicable
diseases are on rise. In the current article, we propose that dysfunction of the mesocortico-limbic …
diseases are on rise. In the current article, we propose that dysfunction of the mesocortico-limbic …
[HTML][HTML] Blockade of TMPRSS2-mediated priming of SARS-CoV-2 by lactoferricin
In addition to vaccines, there is an urgent need for supplemental antiviral therapeutics to
dampen the persistent COVID-19 pandemic caused by the severe acute respiratory syndrome …
dampen the persistent COVID-19 pandemic caused by the severe acute respiratory syndrome …
[HTML][HTML] sVmKTx, a transcriptome analysis-based synthetic peptide analogue of Vm24, inhibits Kv1. 3 channels of human T cells with improved selectivity
… Δ G = G PL - G P - G L was calculated, where G PL , G P and G L are … G = G MM + G Solv ,
where G M M is the calculated molecular mechanics energy for the force field applied, and G S …
where G M M is the calculated molecular mechanics energy for the force field applied, and G S …
[HTML][HTML] Optimization of Pichia pastoris expression system for high-level production of margatoxin
Margatoxin (MgTx) is a high-affinity blocker of voltage-gated potassium (Kv) channels. It inhibits
Kv1.1–Kv1.3 ion channels in picomolar concentrations. This toxin is widely used to study …
Kv1.1–Kv1.3 ion channels in picomolar concentrations. This toxin is widely used to study …
[HTML][HTML] The voltage-gated proton channel hHv1 is functionally expressed in human chorion-derived mesenchymal stem cells
… G, Comparison of closure responses of MSCs following treatment with ClGBI (100 µM) over
41.3 hours versus control non-treated MSCs. Closure% = [(initial cell free are − cell free are …
41.3 hours versus control non-treated MSCs. Closure% = [(initial cell free are − cell free are …
